Bradykinin potentiatorE (9CI)(30807-90-0)
- Name: Bradykinin potentiatorE (9CI)
- Synonyms:Proline,1-[1-[N-[N-[1-[1-[1-[N-[N-[N2-(5-oxo-L-prolyl)-L-lysyl]-L-tryptophyl]-L-a-aspartyl]-L-prolyl]-L-prolyl]-L-prolyl]-L-valyl]-L-seryl]-L-prolyl]-,L- (8CI); Bradykinin-potentiating peptide E (Agkistrodon halys blomhoffiivenom); L-Proline,1-[1-[N-[N-[1-[1-[1-[N-[N-[N2-(5-oxo-L-prolyl)-L-lysyl]-L-tryptophyl]-L-a-aspartyl]-L-prolyl]-L-prolyl]-L-prolyl]-L-valyl]-L-seryl]-L-prolyl]-
- Molecular Formula:C59H83 N13 O16
- Molecular Weight:
- CAS Registry Number:30807-90-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 68201-70-7/Benzenesulfonic acid, sulfonylbis(hydroxymethyl-, tetrasodium salt,polymer with formaldehyde, sulfonylbis(hydroxybenzenesulfonic acid) tetrasodium salt and 2,2-sulfonylbis(phenol) disodium salt
- 74039-51-3/Sulfurous acid 2-chloro-3-(allyloxy)propyl 2-chloroethyl ester
- 635-26-7/O-TOLYLHYDRAZINE HYDROCHLORIDE
- 50583-06-7/Halonamine
- 91697-93-7/FEMA No. 2092
- 51796-22-6/L-Ascorbic acid,compounds,mixt. with 3-[(4-amino-2-methyl-5-pyrimidinyl)- methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride,(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and riboflavin
- 85080-81-5/sodium 2-benzo[f]quinolin-3-yl-1,3-dioxoindansulphonate
- 72139-08-3/Nickelate(8-), bis(3-((2-(amino-kappaN)-8-hydroxy-6-sulfo-1-naphthalenyl)azo-kappaN1)-2-(hydroxy-kappaO)-5-sulfobenzoato(5-))-, hexasodium dihydrogen
- 69847-25-2/3-Methoxybenz[a]anthracene
- 124154-20-7/1,2-bis(10(2',4'-hexadienoyloxy)decanoyl)-sn-glycero-3-phosphocholine
- 88849-65-4/1,4-cyclohexanedimethanol-3,9-diethylidene-2,4,8,10-tetraoxaspiro(5.5)undecane-1,6-hexanediol polymer
- 111394-45-7/Combretastatin A-3
- 39380-12-6/FEROLINE
- 78542-61-7/2H-1,3,2-Oxazaphosphorine, tetrahydro-2-(bis(2-chloroethyl)amino)-5-ch loro-, 2-oxide, (Z)-
- 667-91-4/9-BENZHYDRYLIDENE-10-ANTHRONE
- 6439-62-9/1-chloro-4-{[4-(4-ethoxyphenoxy)butyl]sulfanyl}benzene
- 5326-76-1/1-(2-hydroxyethyl)-6-methyl-1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
- 85068-68-4/2-[[3-(dodecyloxy)propyl][2-(2-hydroxyethoxy)ethyl]amino]ethanol
- 83459-41-0/Ginsenoside Ra1
- 30807-90-0/Bradykinin potentiatorE (9CI)
- 72650-00-1/5-methyl-2-(2,3,5,6-tetramethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride
- 128165-34-4/g-Cyclodextrin,2A,2B,2C,2D,2E,2F,2G,2H,6A,6B,6C,6D,6E,6F,6G,6H-hexadeca-O-pentyl-,3A,3B,3C,3D,3E,3F,3G,3H-octakis(trifluoroacetate)
- 15523-43-0/1-(2-Ethoxyethoxy)-2-(hexyloxy)ethane
- 367-44-2/DIETHYL ALUMINUM FLUORIDE
- 27052-83-1/3-chloro-4-methyl-N-[(2E)-1-(prop-2-en-1-yl)pyrrolidin-2-ylidene]aniline
- 69121-24-0/trisodium [3-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-2-hydroxy-5-sulphophenyl]azo]-4-hydroxynaphthalene-2,7-disulphonato(5-)]cuprate(3-)
- 101255-45-2/butanoic acid - 1-methyl-4-phenylpiperidin-4-ol hydrochloride (1:1:1)
- 591-19-5/3-Bromoaniline
- 134134-07-9/triethyl{[4-(4-propyl-2,6,7-trioxabicyclo[2.2.2]oct-1-yl)phenyl]ethynyl}silane
- 71712-36-2/5-(4-ethoxy-3-methylbenzyl)-1,3-benzodioxole